Fluid Therapy: Clinical Trials

123 trials of Fluid Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

67 completed, 22 unknown, 14 recruiting, 6 active not recruiting. 43 Not applicable, 21 Phase 3, 20 Phase 2, 15 Phase 1, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable43Completed 26, Unknown 9, Recruiting 3, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1
Phase 321Completed 12, Active not recruiting 3, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 220Completed 7, Recruiting 5, Unknown 5, Active not recruiting 2, Suspended 1
Phase 115Completed 9, Recruiting 2, Active not recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 413Completed 8, Terminated 2, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 14Completed 1, Recruiting 1, Terminated 1, Unknown 1

Follow Fluid Therapy: new trials by email Literature Review of Fluid Therapy trials Research Report on Fluid Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SGB for Prevention of Postop A-Fib After Cardiac SurgeryTrial
Stellate Ganglion Block Injection with 10 mL 0.5% Bupivacaine, Stellate Ganglion Block Injection with 10 mL Normal Saline - Atrial Fibrillation, Postoperative Atrial Fibrillation
Phase 3Not yet recruitingThe Cleveland Clinic602026-10-152026-10-27
Safety of Topical Exosome-Containing Liquid in Healthy Volunteers
Exosome-Containing Liquid, Vehicle Liquid - Skin Irritation, Healthy Volunteers
Phase 1Active not recruitingWest Kazakhstan Marat Ospanov Medical University102026-09-252026-10-09
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
IgPro20 - Secondary Immune Deficiency
Phase 3RecruitingCSL Behring632026-09-152026-10-14
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment
Lidocaine (drug), Saline - Refractory Migraine, Headache
Phase 2RecruitingDaniel A Tonetti, MD802026-09-092026-10-01
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Biospecimen Collection, Placebo Administration, Probiotic - Advanced Ovarian Carcinoma, Recurrent Ovarian Carcinoma
Early Phase 1RecruitingOhio State University Comprehensive Cancer Center1612026-03-062026-08-17
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Rifaximin 200 mg Tablet, Oral Rehydration Therapy (ORT) - Diarrhea, Gastroenteritis
Phase 4RecruitingBausch Health Americas, Inc.542026-02-112026-08-13
EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES
Melatonin, intravenous (IV) fluids, intensive monitoring, broad-spectrum antibiotic cover - Hypoxic Ischaemic Encephalopathy (HIE)
Phase 2Active not recruitingUniversity of Child Health Sciences and Children's Hospital, Lahore1102025-12-102025-12-26
Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis
Vasopressors, Fluids - Septic Shock, Fluid Resuscitation
Not yet recruitingAustralian and New Zealand Intensive Care Research Centre78382025-11-012025-01-03
Oral Versus Intravenous Fluid Therapy in the Emergency Department
Oral fluids, Intravenous fluids - Fluid Management
Not applicableRecruitingEsbjerg Hospital - University Hospital of Southern Denmark2502025-10-032026-01-23
Two Cut-Off Values of Plethysmographic Variability Index to Guide Intraoperative Fluid Therapy on Serum Lactate in Patients Undergoing Excision of Supra-Tentorial Brain Tumors
Fluid Therapy - Cut-Off Value, Plethysmographic Variability Index
Not applicableCompletedCairo University322025-09-202026-04-21
Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema
Fluid Therapy, Indocyanine Green, Questionnaire Administration - Breast Cancer-Related Lymphedema, Breast Carcinoma
Not applicableWithdrawnCity of Hope Medical Center2025-08-142025-09-17
An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
IgPro - Primary Immunodeficiency
Phase 4CompletedCSL Behring82025-07-152026-07-16
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
Fluid therapy, Noradrenaline infusion - Sepsis, Septic Shock
Not applicableNot yet recruitingGeneral and Teaching Hospital Celje302025-02-012025-03-03
A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity
AMG 133 (frozen liquid), AMG 133 (liquid) - Overweight and Obesity
Phase 1CompletedAmgen1542024-11-262026-07-21
Patient Controlled Administration of Liquid Acetaminophen
Acetaminophen 650 mg Oral Tablet, Acetaminophen 650mg Liquid, CADD pump - Pain, Pain, Postoperative
Phase 1CompletedYale University242024-11-192026-08-06
Inferior Vena Cava Collapsibility Index Guide for Preoperative Fluid Therapy in Preeclampsia
fluid therapy, 300 ml of crystalloid Ringer's solution. - Pre-Eclampsia, Hypotension
Not applicableUnknownAin Shams University902024-08-152024-10-29
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia
Phase 2RecruitingFred Hutchinson Cancer Center542024-07-232026-10-26
Early Resuscitation in Paediatric Sepsis Using Inotropes
Fluid, Adrenalin - Sepsis
Phase 2UnknownNATALIA LOPERA MUNERA402024-07-012024-06-27
Oral Fluid vs IV Fluid After Primary TKA
Oral fluid, IV fluid - Osteoarthritis, Knee, Total Knee Arthroplasty
Not applicableUnknownThammasat University Hospital1302024-01-102024-03-04
Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
Belantamab Mafodotin, Biospecimen Collection, Bone Marrow Aspirate - Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Phase 2RecruitingMayo Clinic622024-01-042026-07-14

Showing 20 of 123. Sign in to see all of them.

Conditions studied

Shock, Septic (7)  ·  Sepsis (5)  ·  Dehydration (4)  ·  Primary Immunodeficiency Diseases (4)  ·  Diarrhea (3)  ·  Emergencies (3)  ·  Epilepsy (3)  ·  Gastroenteritis (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Multiple Myeloma (3)  ·  Pain (3)  ·  Acute Kidney Injury (2)  ·  COVID-19 (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Edema (2)

Sponsors

Cairo University (5)  ·  Ain Shams University (3)  ·  MedImmune LLC (3)  ·  The Cleveland Clinic (3)  ·  Australian and New Zealand Intensive Care Research Centre (2)  ·  CSL Behring (2)  ·  Green Cross Corporation (2)  ·  Johns Hopkins University (2)  ·  Mayo Clinic (2)  ·  National Cancer Institute (NCI) (2)  ·  Sanofi (2)  ·  University of Calgary (2)  ·  Adenobio N.V (1)  ·  Al Hayat National Hospital (1)  ·  Alternative Research Initiative (1)

Countries

United States (49)  ·  Egypt (12)  ·  Canada (11)  ·  France (8)  ·  Spain (8)  ·  China (7)  ·  Germany (5)  ·  Denmark (4)  ·  United Kingdom (4)  ·  Australia (3)  ·  Brazil (3)  ·  Hungary (3)  ·  Poland (3)  ·  Saudi Arabia (3)  ·  South Korea (3)

Top investigators

Robert Walker, MD (2)  ·  Ahmed A Mahmoud Sayed, Professor (1)  ·  Ahmed El Zohairy, PhD (1)  ·  Ahmed Maged, MD (1)  ·  Ahmed Traigey, MD (1)  ·  Amir Kugelman, MD (1)  ·  Ann Dahlberg (1)  ·  Atunga Nyachieo, PhD Biomedical Sciences (1)  ·  Barbara Pena, MD (1)  ·  Betsy Lozoff, MD (1)  ·  Beverly C Walters, MD (1)  ·  Candice Jersey, D.O. (1)

Results publications

PMID 17822565, PMID 17973110, PMID 18182756, PMID 18450135, PMID 19502035, PMID 20123766, PMID 22739142, PMID 23260101, PMID 24280471, PMID 25080428, PMID 25619263, PMID 26240596, PMID 26768569, PMID 27039941, PMID 27049826, PMID 27836288, PMID 27874837, PMID 27894428, PMID 28137530, PMID 28185689, PMID 28277352, PMID 28296829, PMID 28526048, PMID 28817481, PMID 29880162, PMID 29940135, PMID 29980460, PMID 30077561, PMID 30231787, PMID 30682573, PMID 31119515, PMID 31181017, PMID 31289908, PMID 31318772, PMID 31500875, PMID 31693429, PMID 32705923, PMID 32727709, PMID 32770353, PMID 33028076, PMID 33288485, PMID 33855080, PMID 34041648, PMID 34305948, PMID 34749395, PMID 34903176, PMID 35044877, PMID 35086141, PMID 35217576, PMID 35944615

NIH funding

2015 (2), U10CA180820 (2), 2014 (1), P01HD039386 (1), P30CA033572 (1), R01AI165327 (1), R35GM146822 (1), U10CA180868 (1), U19AI101961 (1), UM1CA228823 (1)